Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02134509 · ClinicalTrials.gov registry record · NA
Smartphone Application for Smoking Cessation
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 511
- Enrollment target
NCT02134509: Completed NA study, sponsored by Yale University.
NCT02134509 is a NA study that has completed, run by Yale University. The registered enrollment target is 511 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02134509, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 511 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effectiveness of a smartphone application for smoking cessation in smokers ages 18 to 65 years.
Primary Outcome
Subjects will be assessed for smoking abstinence at a 6-month follow-up.
Interventions
- BEHAVIORAL Experimental App
- BEHAVIORAL Active Comparator App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 511 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02134509 record still lists
NCT02134509 is an interventional study that assigns participants to a tested intervention. The registered 511 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 2 interventions - of which Experimental App is the first listed.
NCT02134509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02134509 about?
NCT02134509 is a clinical study titled "Smartphone Application for Smoking Cessation". The purpose of this study is to test the effectiveness of a smartphone application for smoking cessation in smokers ages 18 to 65 years.
What is the current status of trial NCT02134509?
This trial is currently completed. It is a NA study. The enrollment target is 511 participants. The study started on 2014-10. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02134509?
The interventions under investigation include: Experimental App (BEHAVIORAL), Active Comparator App (BEHAVIORAL).
Who is sponsoring clinical trial NCT02134509?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02134509's enrollment target sits among peer trials
511 192nd of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia